DIMENSIONAL FUND ADVISORS LP

Position in GRAL — GRAIL, Inc.

CIK 354204 AUSTIN, TX

Position in GRAL

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$46,395,402

+$25,276,373 QoQ

Shares Held

679,587

+66.3% QoQ

Ownership

1.52%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#15

of 374 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 91% Shared 6% None 3%

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $5,660,397,604 across 32 Diagnostics & Research names. GRAL ranks #20 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	1,712,845	$858,751,967
2	DHR	Danaher Corp /De/	2,651,651	$505,086,479
3	DGX	Quest Diagnostics Inc	1,988,048	$421,366,772
4	LH	Labcorp Holdings Inc.	1,367,166	$382,806,480
5	RVTY	Revvity, Inc.	3,428,692	$381,476,269
6	CRL	Charles River Laboratories International, Inc.	1,648,450	$373,851,972
7	IQV	Iqvia Holdings Inc.	1,735,452	$335,324,034
8	IDXX	Idexx Laboratories Inc /De	608,902	$320,550,366

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$46,395,402	679,587	+66.3%	Shares	Sole	2026-08-11
2026-03-31	$21,119,029	408,650	+88.5%	Shares	Sole	2026-05-07
2025-12-31	$18,555,309	216,793	+364.7%	Shares	Sole	2026-02-12
2025-09-30	$2,758,354	46,649	-2.7%	Shares	Sole	2025-11-12
2025-06-30	$2,464,249	47,924	+0.0%	Shares	Sole	2025-08-12
2025-03-31	$1,223,646	47,911	-0.5%	Shares	Sole	2025-05-13
2024-12-31	$859,512	48,152	-0.2%	Shares	Sole	2025-02-13
2024-09-30	$664,124	48,265	-5.1%	Shares	Sole	2024-11-07
2024-06-30	$781,885	50,871	—	Shares	Sole	2024-08-09
No filing history on record for this holder in this stock.